Abbott Labs (ABT)
Company | Ticker | Sector | Industry | Quality | PAR |
---|---|---|---|---|
Abbott Labs | ABT | Healthcare | Medical Devices | 93 | 7.4% |
Current Price ( 3/18 4:00PM EDT) | $112.44 | |||
CAPS Rating (Rate this stock on CAPS) | ||||
Expected Income Statement | ||||
Current Sales | 40,109.0 | |||
Sales Growth Forecast | 6.2% | |||
Net Profit Margin | 21.4% | |||
Projected Shares Outstanding | 1,730.16 | |||
EPS - Five year Forecast | $6.71 | |||
Average P/E Ratio | 22.0 | |||
Projected Average Price | $147.57 | |||
Price Appreciation (Annualized) | 5.6% | |||
Annual Dividend Yield | 1.8% | |||
Projected Annual Return | 7.4% | |||
Quality | ||||
Financial Strength | 95 | 23.8 | ||
EPS Stability | 93 | 23.2 | ||
Industry Sales Growth Rate | 11.5% | 6.8 | ||
Industry Net Profit Margin | 15.5% | 17.3 | ||
Calculated Quality Rating | 74.4 | |||
Fool CAPS | ||||
Total Players
2485
Outperforms
96
Underperforms
All-Stars (443)
428
Outperforms (97%)
15
Underperforms
|
||||
Fundamental Data Updated: 02/09/2024 |